Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
Amicus Therapeutics (FOLD) has scheduled its first quarter 2025 financial results conference call and audio webcast for Thursday, May 1, 2025, at 8:30 a.m. ET. The event will cover financial performance for Q1 ending March 31, 2025.
Participants must pre-register online to receive dial-in details and a personal PIN for phone access. A live webcast and presentation materials will be available through the Investors section at ir.amicusrx.com, with recommended registration 15 minutes before the call. An archived version and slides will be accessible post-event on the company website.
Amicus Therapeutics (FOLD) ha programmato la conference call e la trasmissione audio in webcast dei risultati finanziari del primo trimestre 2025 per giovedì 1 maggio 2025, alle 8:30 ET. L'evento riguarderà la performance finanziaria del primo trimestre terminato il 31 marzo 2025.
I partecipanti devono registrarsi online in anticipo per ricevere i dettagli per la chiamata e un PIN personale per l'accesso telefonico. Una diretta webcast e i materiali della presentazione saranno disponibili nella sezione Investitori su ir.amicusrx.com, con la raccomandazione di registrarsi 15 minuti prima della chiamata. Una versione registrata e le slide saranno accessibili dopo l'evento sul sito web aziendale.
Amicus Therapeutics (FOLD) ha programado su conferencia telefónica y webcast de audio para los resultados financieros del primer trimestre de 2025 para el jueves 1 de mayo de 2025 a las 8:30 a.m. ET. El evento cubrirá el desempeño financiero del primer trimestre que finaliza el 31 de marzo de 2025.
Los participantes deben registrarse en línea previamente para recibir los detalles de acceso y un PIN personal para la llamada telefónica. Un webcast en vivo y los materiales de la presentación estarán disponibles en la sección de Inversores en ir.amicusrx.com, recomendándose registrarse 15 minutos antes de la llamada. Una versión archivada y las diapositivas estarán accesibles después del evento en el sitio web de la empresa.
Amicus Therapeutics (FOLD)는 2025년 1분기 재무 실적 컨퍼런스 콜 및 오디오 웹캐스트를 2025년 5월 1일 목요일 오전 8시 30분(동부시간)에 예정했습니다. 이번 행사는 2025년 3월 31일로 종료되는 1분기 재무 성과를 다룹니다.
참가자는 전화 접속 정보와 개인 PIN을 받기 위해 사전 온라인 등록이 필요합니다. 라이브 웹캐스트와 발표 자료는 ir.amicusrx.com의 투자자 섹션에서 제공되며, 콜 시작 15분 전에 등록하는 것이 권장됩니다. 행사 후 회사 웹사이트에서 녹화본과 슬라이드를 확인할 수 있습니다.
Amicus Therapeutics (FOLD) a programmé sa conférence téléphonique et son webcast audio des résultats financiers du premier trimestre 2025 pour le jeudi 1er mai 2025 à 8h30 ET. L'événement portera sur la performance financière du premier trimestre clos le 31 mars 2025.
Les participants doivent s'inscrire en ligne à l'avance pour recevoir les détails de connexion et un code PIN personnel pour l'accès téléphonique. Un webcast en direct et les documents de présentation seront disponibles dans la section Investisseurs sur ir.amicusrx.com, avec une inscription recommandée 15 minutes avant l'appel. Une version archivée et les diapositives seront accessibles après l'événement sur le site web de la société.
Amicus Therapeutics (FOLD) hat seine Telefonkonferenz und Audio-Webcast zu den Finanzergebnissen des ersten Quartals 2025 für Donnerstag, den 1. Mai 2025, um 8:30 Uhr ET angesetzt. Die Veranstaltung behandelt die finanzielle Leistung für das am 31. März 2025 endende erste Quartal.
Teilnehmer müssen sich online vorregistrieren, um Einwahldaten und eine persönliche PIN für den Telefonzugang zu erhalten. Ein Live-Webcast und Präsentationsmaterialien sind im Investor-Bereich unter ir.amicusrx.com verfügbar, empfohlen wird eine Registrierung 15 Minuten vor Beginn des Calls. Eine Aufzeichnung und die Folien sind nach der Veranstaltung auf der Unternehmenswebseite abrufbar.
- None.
- None.
PRINCETON, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 1, 2025, at 8:30 a.m. ET to discuss financial results for the first quarter ended March 31, 2025.
Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.
An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FAQ
When will Amicus Therapeutics (FOLD) release Q1 2025 earnings?
How can investors join the Amicus Therapeutics Q1 2025 earnings call?
Where can I find the replay of FOLD's Q1 2025 earnings call?
What period will FOLD's upcoming earnings report cover?
